TIGIT is often coexpressed with PD-1; therefore, combination blockade of TIGIT and PD-1 could reverse functional exhaustion more effectively, as displayed in patients with advanced melanoma, who showed increased expansion and an elicited anti-tumor immune response (65). The gene discussed is TIGIT; the disease is neoplasm.